18 results
424B5
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Prospectus supplement for primary offering
4:11pm
than 5% of our common stock;
persons who have elected to mark securities to market; and
persons holding our common stock as part of a hedging
424B5
ABOS
Acumen Pharmaceuticals Inc
17 Jul 23
Prospectus supplement for primary offering
4:49pm
common stock;
persons who have elected to mark securities to market; and
persons holding our common stock as part of a hedging or conversion transaction
424B5
5g8kf17e umu
27 Apr 23
Prospectus supplement for primary offering
7:06am
PRE 14A
u109q35iuqs6y
14 Apr 23
Preliminary proxy
4:33pm
S-3
gczd 4ka34r7
1 Jul 22
Shelf registration
5:06pm
DEF 14A
t1gf zxl97m
27 Apr 22
Definitive proxy
5:03pm
10-K
stc7bn3bgwn2 lm
28 Mar 22
Annual report
4:51pm
10-Q
0a0a r7y130bx
16 Aug 21
Quarterly report
4:51pm
424B4
el2p66zf 09ss
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
qpes 34hiz
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.2
7cn8nn0pythmmm3s
24 Jun 21
IPO registration (amended)
8:17am
S-1
2lwm7m5xk54 tlkkjayb
9 Jun 21
IPO registration
5:02pm
DRS/A
r45u9r257
14 May 21
Draft registration statement (amended)
12:00am
DRS
v6yorzkmz3b
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next